Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]

Tahir N, Madni A, Correia A, et al. Int J Nanomed.  2019;14:4961– 4974.  On page 4967, Figure 3 artwork is incorrect, Figure 4 artwork was mistakenly added by the Editorial staff during the publication process.Read the original article

Guardado en:

Detalles Bibliográficos
Autores principales:	Tahir N, Madni A, Correia A, Rehman M, Balasubramanian V, Khan MM, Santos HA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/88a4e47174c54953b8a9e3413f29cb35
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:88a4e47174c54953b8a9e3413f29cb35
record_format	dspace
spelling	oai:doaj.org-article:88a4e47174c54953b8a9e3413f29cb352021-12-02T06:40:08ZLipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]1178-2013https://doaj.org/article/88a4e47174c54953b8a9e3413f29cb352020-02-01T00:00:00Zhttps://www.dovepress.com/erratum-lipid-polymer-hybrid-nanoparticles-for-controlled-delivery-of--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Tahir N, Madni A, Correia A, et al. Int J Nanomed.  2019;14:4961– 4974.  On page 4967, Figure 3 artwork is incorrect, Figure 4 artwork was mistakenly added by the Editorial staff during the publication process.Read the original articleTahir NMadni ACorreia ARehman MBalasubramanian VKhan MMSantos HADove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 839-840 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
description	Tahir N, Madni A, Correia A, et al. Int J Nanomed.  2019;14:4961– 4974.  On page 4967, Figure 3 artwork is incorrect, Figure 4 artwork was mistakenly added by the Editorial staff during the publication process.Read the original article
format	article
author	Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA
author_facet	Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA
author_sort	Tahir N
title	Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
title_short	Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
title_full	Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
title_fullStr	Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
title_full_unstemmed	Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
title_sort	lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy [erratum]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/88a4e47174c54953b8a9e3413f29cb35
work_keys_str_mv	AT tahirn lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT madnia lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT correiaa lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT rehmanm lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT balasubramanianv lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT khanmm lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum AT santosha lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapyerratum
_version_	1718399763557122048

Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]

Ejemplares similares